Scary guy

Commenter guest reminded us that Jack Turban has conflicts of interest. Let’s refresh our memories on those conflicts.

Uncommon ground in August 2020:

Jack Turban, insistent critic of Abigail Shrier’s book on transitioning of young girls, constantly claims puberty blockers are safe. He is paid by a firm that manufactures them.

And this isn’t, like, an acne cream or an over the counter cold remedy. It’s halting an adolescent’s puberty, with all the attendant consequences we’ve been learning about over the past several years. It’s a very drastic intervention, even if you believe everyone who claims to be trans really is trans and really does need medical intervention. If you believe that at least some people who claim that are ensnared by a fad as opposed to really trans, then it’s even worse. Jack Turban accepts money from people who profit from the interventions.

Jack Turban, MDfellow in child and adolescent psychiatry at Stanford University School of medicine, bills himself as an Allopathic & Osteopathic Physician. But he’s famous for his advocacy for certain positions regarding transgender medicine – for advocating for the ‘Gender Affirming Care for Trans and ‘gender-diverse’ youth’ as part of his work on ‘Pediatric Gender Identity’ and vigorously advocating for, and downplaying the risks of, medical transition, while selling books on the same.

Again, “gender-affirming” care is very drastic. It seems like the kind of thing medical professionals ought to treat with caution and low speed and more caution.

He is most popular for labeling any medical professional or medical research that finds success in psychosocial treatments for kids with gender identity disorder, without putting them on puberty blockers and setting them on a path to cross sex hormone treatment and surgery, as ‘conversion therapy,’ that awful throwback to electroshock torture of gay people.

Case in point:

When in doubt…trans all the children. Especially if there’s money in it.

According to Open Payments Search Tool used to track payments made by drug and medical device companies to physicians and teaching hospitals, Jack Turban has received at least  $15,000 (US) from Arbor Pharmaceuticals, manufacturers of Triptodur™, (triptorelin) which, through extended release injectable suspension, has been shown to arrest or reverse the clinical signs of puberty, in cases of precocious puberty – the exact purpose Arbor advocates Triptodur for.

Now if this were a matter of a medication that has some risks but also has unmistakable benefits for unmistakable physical problems, it would be a more complicated story, but the purported benefits of “gender-affirming care” are so heavily dependent on believing in the ideology of fungible gender that it becomes very difficult (or just sinister) to say “Yes it’s risky but it’s worth the risk.” Doing so while accepting money from the makers of the medication is not a good look.

5 Responses to “Scary guy”